No insider purchase over the last 90 days. The latest, by 휴온스글로벌, was filed 27 Apr 2026.
Who traded when
BuySaleSince the insiders bought
- -39.6%Entry ₩37,500 · Close 30 Oct 2026 ₩22,650
- -39.6%Entry ₩37,500 · Close 30 Oct 2026 ₩22,650
- -6.7%Entry ₩42,600 · Close at T+365 ₩39,750
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 7,658 sharesKRXDART:20260427000036Canonical exit: 22 Jul 2026 (T+90)
- 5,711 shares@ ₩35,030.50180.067% mcap100.0% of flowShareKRXDART:20260427000019Canonical exit: 21 Jul 2026 (T+90)
- ●Executives0DART
- 246,892 sharesKRXDART:20260210000856
- 156,797 sharesKRXDART:20250808000471Canonical exit: 30 Sept 2025 (T+90)
- 417 sharesShareKRXDART:20250709000348
- Other0DART
- 6,595 sharesKRXDART:20250530001642
- ●Executives0DART
- 1,947 sharesShareKRXDART:20241224000434Canonical exit: 24 Mar 2025 (T+90)
- 9,557 sharesKRXDART:20240731000616Canonical exit: 22 Oct 2024 (T+90)
- ●Executives0DART
- 9,557 sharesKRXDART:20230901000020Canonical exit: 23 Nov 2023 (T+90)
- ShareKRXDART:20230830000342
- ShareKRXDART:20230830000330
- ShareKRXDART:20230824000327
- ShareKRXDART:20230525000413
- 9,557 sharesKRXDART:20230407003339Canonical exit: 6 Jul 2023 (T+90)
- ●Executives0DART
- 4,932 sharesShareKRXDART:20230111000317
- 9,557 sharesKRXDART:20220718000293Canonical exit: 16 Oct 2022 (T+90)
- 9,557 sharesKRXDART:20220429001460Canonical exit: 28 Jul 2022 (T+90)
- 9,557 sharesKRXDART:20220407002572Canonical exit: 6 Jul 2022 (T+90)
- ●Executives0DART
- ShareKRXDART:20211008000525
25 of 31 declarations
About Humedix Co., Ltd.
휴메딕스 (Humedix Co., Ltd.) sees its purchases come mostly from one shareholder: 휴온스글로벌 (대량보유자), with 7 purchases and one sale across 8 filings, plus another purchase filed under a second entry. The only purchase with an amount is by 윤연상 (이사), EUR 115,434 on April 22, 2026. 배준규 (상무이사) has 10 filings including one purchase, 브이아이피자산운용 (대량보유자) one purchase and one sale, and the company 6 filings with no trade.
Between April 22 and April 23, 2026, 2 distinct filers bought. Counting trades, 11 purchases face 4 sales (73% purchases), with no other amount. Publication spans March 4, 2021 to April 27, 2026 for 30 filings, of which 15 are neither purchases nor sales; by year, 7 in 2021, 4 in 2022, 8 in 2023, 3 in 2024, 4 in 2025 and 4 in 2026.
Read moreShow less
South Korean health care at KRW 267.3 billion, 37.5% of the capital with insiders, 8 filers. Publication delay of 7 days at the median. Latest year: 4 filings, including 2 purchases and one sale.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
